Unlocking Q3 Potential of Clorox (CLX): Exploring Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Clorox (CLX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Clorox a Safe Dividend Stock to Buy Right Now?
Clorox (CLX 2.06%) thrived during the pandemic but has had trouble generating growth ever since.
Clorox Australia fined $5.2 million over false claims of using recycled plastic
Australia's competition regulator said on Monday Clorox's local unit had been fined A$8.25 million ($5.19 million) by the Federal Court over falsely claiming its GLAD kitchen and garbage bags were partially made from recycled ocean plastic.
Here's How You Should Play Clorox Stock After a 12% Drop in 6 Months
CLX is navigating short-term pressures while leaning on its IGNITE strategy and digital transformation to spark long-term growth and shareholder value.
Clorox Announces May 5 Webcast of Third-Quarter Fiscal Year 2025 Results
OAKLAND, Calif. , April 9, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its third-quarter fiscal year 2025 results on May 5, 2025.
Hidden Valley® Ranch Unveils Seven Bold New Flavors
The brand's product innovations and reimagined packaging hit shelves now OAKLAND, Calif. , April 4, 2025 /PRNewswire/ -- Hidden Valley® Ranch, the brand known for delicious, versatile condiments and seasonings, is taking its flavor game to the next level.
Why Clorox (CLX) is Poised to Beat Earnings Estimates Again
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Clorox: Stable Revenue And Strong Dividend Program, But Too Expensive
Clorox is considered recession-proof due to its essential products and strong brand, but its shares are too expensive, given its profitability. CLX has underperformed the market significantly, facing competition and changing consumer preferences, which limits its growth and profitability. Despite stable revenue, CLX's high operating costs and declining margins make it less attractive compared to tech giants with better growth prospects.
Clorox's Strategic Vision Entails Balancing Growth Amid Cost Woes
CLX navigates cost challenges while driving growth through strategic investments, innovation and global expansion.
Zacks Industry Outlook The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox
The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox have been highlighted in this Industry Outlook article.
